BRÈVE publiée le 31/07/2024 à 19:50, il y a 3 mois 20 jours Le programme Pompa nommé dans le classement Fast 50 Emerging Companies 2024 du Utah Business Magazine Santé Et Bien-être Croissance Des Entreprises Rapide 50 Entreprises Émergentes Magazine Économique De L'Utah
BRÈVE publiée le 31/07/2024 à 19:50, il y a 3 mois 20 jours Pompa Program Named in Utah Business Magazine's 2024 Fast 50 Emerging Companies Business Growth Health And Wellness Emerging Companies Fast 50 Utah Business Magazine
COMMUNIQUÉ DE PRESSE publié le 31/07/2024 à 19:45, il y a 3 mois 20 jours Pompa Program Named as One of Utah Business Magazine's 2024 Fast 50 Emerging Companies Pompa Program named finalist in Utah Business Magazine's Fast 50 Emerging Companies list, recognized for exceptional growth and impact in health and wellness industry Health And Wellness Emerging Companies Fast 50 Pompa Program Utah Business Magazine
BRÈVE publiée le 19/07/2024 à 15:05, il y a 4 mois 1 jour New Insights Into Which Food Ingredients to Avoid Artificial Sweeteners Food Colorants Processed Meats High Fructose Corn Syrup Vegetable Oils
BRÈVE publiée le 19/07/2024 à 15:05, il y a 4 mois 1 jour Nouvelles informations sur les ingrédients alimentaires à éviter Édulcorants Artificiels Colorants Alimentaires Viandes Transformées Sirop De Maïs Riche En Fructose Les Huiles Végétales
COMMUNIQUÉ DE PRESSE publié le 19/07/2024 à 15:00, il y a 4 mois 1 jour New Insights Into Which Food Ingredients to Avoid Dr. Daniel Pompa reveals studies on top 5 toxic food ingredients to avoid, including artificial sweeteners, harmful colorants, processed meats, high fructose corn syrup, and vegetable oils. Learn more at pompaprogram.com Health Risks Dr. Daniel Pompa Pompa Program Toxic Food Ingredients Avoid
BRÈVE publiée le 18/07/2024 à 23:00, il y a 4 mois 2 jours Le Dr Daniel Pompa partage des études qui révèlent la cause principale de l'acné Epigénétique Causes De L'acné Facteurs Génétiques Régulation Hormonale Perturbateurs Endocriniens
BRÈVE publiée le 18/07/2024 à 23:00, il y a 4 mois 2 jours Dr. Daniel Pompa Shares Studies That Reveal the Core Cause of Acne Epigenetics Acne Causes Genetic Factors Hormone Regulation Endocrine Disruptors
COMMUNIQUÉ DE PRESSE publié le 18/07/2024 à 22:55, il y a 4 mois 2 jours New Insights Into What Causes Acne Dr. Daniel Pompa discusses genetic and epigenetic factors in acne development, highlighting immune system regulation and hormone production. Learn more from Pompa Program Dr. Daniel Pompa Pompa Program Acne Causes Genetic Factors Epigenetic Changes
BRÈVE publiée le 09/07/2024 à 19:05, il y a 4 mois 11 jours New Insights Into the Link Between Cellular Health and Unexplained Weight Gain Toxins Cellular Health Weight Gain Hormone Resistance Metabolism
Publié le 21/11/2024 à 06:58, il y a 6 heures 42 minutes Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 6 heures 42 minutes Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 6 heures 42 minutes Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 17 heures 33 minutes Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 18 heures 20 minutes Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Publié le 21/11/2024 à 13:30, il y a 10 minutes AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Publié le 21/11/2024 à 13:30, il y a 10 minutes Datametrex Secures Additional P.O. Approx $250K for IT Services
Publié le 21/11/2024 à 13:00, il y a 40 minutes Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Publié le 21/11/2024 à 13:00, il y a 40 minutes Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Publié le 21/11/2024 à 13:00, il y a 40 minutes Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Publié le 21/11/2024 à 12:35, il y a 1 heure 5 minutes audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Publié le 21/11/2024 à 12:15, il y a 1 heure 25 minutes Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven